Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2031154402', 'doi': 'https://doi.org/10.1158/1535-7163.targ-11-a76', 'title': 'Abstract A76: MDV3100, a novel androgen receptor signaling inhibitor, promotes cell apoptosis and tumor regression in both in vitro and in vivo models of castration-resistant prostate cancer.', 'display_name': 'Abstract A76: MDV3100, a novel androgen receptor signaling inhibitor, promotes cell apoptosis and tumor regression in both in vitro and in vivo models of castration-resistant prostate cancer.', 'publication_year': 2011, 'publication_date': '2011-11-01', 'ids': {'openalex': 'https://openalex.org/W2031154402', 'doi': 'https://doi.org/10.1158/1535-7163.targ-11-a76', 'mag': '2031154402'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-11-a76', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5091752977', 'display_name': 'Sebastián Bernales', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Sebastian Bernales', 'raw_affiliation_strings': ['1Medivation Inc, San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Medivation Inc, San Francisco, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109915997', 'display_name': 'Javier Guerrero', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210108487', 'display_name': 'Fundación Ciencia and Vida', 'ror': 'https://ror.org/01p6hjg61', 'country_code': 'CL', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210108487']}], 'countries': ['CL'], 'is_corresponding': False, 'raw_author_name': 'Javier Guerrero', 'raw_affiliation_strings': ['2Fundacion Ciencia para la VIda, Santiago, Chile;'], 'affiliations': [{'raw_affiliation_string': '2Fundacion Ciencia para la VIda, Santiago, Chile;', 'institution_ids': ['https://openalex.org/I4210108487']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018286697', 'display_name': 'Francisco Javier Gómez', 'orcid': 'https://orcid.org/0000-0003-2435-6207'}, 'institutions': [{'id': 'https://openalex.org/I4210108487', 'display_name': 'Fundación Ciencia and Vida', 'ror': 'https://ror.org/01p6hjg61', 'country_code': 'CL', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210108487']}], 'countries': ['CL'], 'is_corresponding': False, 'raw_author_name': 'Francisco Gomez', 'raw_affiliation_strings': ['2Fundacion Ciencia para la VIda, Santiago, Chile;'], 'affiliations': [{'raw_affiliation_string': '2Fundacion Ciencia para la VIda, Santiago, Chile;', 'institution_ids': ['https://openalex.org/I4210108487']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020279841', 'display_name': 'Iván E. Alfaro', 'orcid': 'https://orcid.org/0000-0002-5938-5940'}, 'institutions': [{'id': 'https://openalex.org/I4210108487', 'display_name': 'Fundación Ciencia and Vida', 'ror': 'https://ror.org/01p6hjg61', 'country_code': 'CL', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210108487']}], 'countries': ['CL'], 'is_corresponding': False, 'raw_author_name': 'Ivan E. Alfaro', 'raw_affiliation_strings': ['2Fundacion Ciencia para la VIda, Santiago, Chile;'], 'affiliations': [{'raw_affiliation_string': '2Fundacion Ciencia para la VIda, Santiago, Chile;', 'institution_ids': ['https://openalex.org/I4210108487']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015449297', 'display_name': 'Kanako Iguchi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I142395110', 'display_name': 'Astellas Pharma (Japan)', 'ror': 'https://ror.org/01cjash87', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I142395110']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kanako Iguchi', 'raw_affiliation_strings': ['3Astellas Pharma Inc, Ibaraki, Japan.'], 'affiliations': [{'raw_affiliation_string': '3Astellas Pharma Inc, Ibaraki, Japan.', 'institution_ids': ['https://openalex.org/I142395110']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069266106', 'display_name': 'Toshiyuki Kusayama', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I142395110', 'display_name': 'Astellas Pharma (Japan)', 'ror': 'https://ror.org/01cjash87', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I142395110']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Toshiyuki Kusayama', 'raw_affiliation_strings': ['3Astellas Pharma Inc, Ibaraki, Japan.'], 'affiliations': [{'raw_affiliation_string': '3Astellas Pharma Inc, Ibaraki, Japan.', 'institution_ids': ['https://openalex.org/I142395110']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5065711515', 'display_name': 'Andrew A. Protter', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Andrew A. Protter', 'raw_affiliation_strings': ['1Medivation Inc, San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Medivation Inc, San Francisco, CA;', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '10', 'issue': '11_Supplement', 'first_page': 'A76', 'last_page': 'A76'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9944, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9944, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12465', 'display_name': 'Cancer, Lipids, and Metabolism', 'score': 0.9483, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10631', 'display_name': 'Cancer, Hypoxia, and Metabolism', 'score': 0.9036, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bicalutamide', 'display_name': 'Bicalutamide', 'score': 0.9624822}, {'id': 'https://openalex.org/keywords/dihydrotestosterone', 'display_name': 'Dihydrotestosterone', 'score': 0.67512757}, {'id': 'https://openalex.org/keywords/hek-293-cells', 'display_name': 'HEK 293 cells', 'score': 0.4361499}], 'concepts': [{'id': 'https://openalex.org/C2780962315', 'wikidata': 'https://www.wikidata.org/wiki/Q1988832', 'display_name': 'Bicalutamide', 'level': 5, 'score': 0.9624822}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.94908106}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.8301655}, {'id': 'https://openalex.org/C2779881493', 'wikidata': 'https://www.wikidata.org/wiki/Q411054', 'display_name': 'Dihydrotestosterone', 'level': 4, 'score': 0.67512757}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.65112543}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5079573}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.47727436}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.44884688}, {'id': 'https://openalex.org/C2777911890', 'wikidata': 'https://www.wikidata.org/wiki/Q62614', 'display_name': 'Androgen', 'level': 3, 'score': 0.44002557}, {'id': 'https://openalex.org/C174510640', 'wikidata': 'https://www.wikidata.org/wiki/Q489618', 'display_name': 'HEK 293 cells', 'level': 3, 'score': 0.4361499}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.39814728}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.39214313}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.34821364}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34238404}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.31973362}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.311826}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.24779576}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.1884096}, {'id': 'https://openalex.org/C71315377', 'wikidata': 'https://www.wikidata.org/wiki/Q11364', 'display_name': 'Hormone', 'level': 2, 'score': 0.120942295}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.07965484}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-11-a76', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.59, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4220880667', 'https://openalex.org/W2911495509', 'https://openalex.org/W2350150322', 'https://openalex.org/W2165911768', 'https://openalex.org/W2095873383', 'https://openalex.org/W2090356696', 'https://openalex.org/W2084616126', 'https://openalex.org/W2076586151', 'https://openalex.org/W2065658150', 'https://openalex.org/W2063882679'], 'abstract_inverted_index': {'Abstract': [0], 'Prostate': [1], 'tumors': [2], 'initially': [3], 'respond': [4], 'to': [5, 54, 143, 159, 315], 'androgen': [6, 28, 166], 'deprivation': [7], 'therapy': [8], 'but': [9], 'eventually': [10], 'progress': [11], 'despite': [12], 'low': [13, 206], 'serum': [14], 'levels': [15], 'of': [16, 61, 70, 85, 119, 170, 193, 200, 219, 269, 276, 299, 332], 'testosterone.': [17], 'In': [18, 157], 'this': [19], 'stage,': [20], 'known': [21], 'as': [22, 37, 172, 205, 207], 'castration-resistant': [23], 'prostate': [24], 'cancer': [25], '(CRPC),': [26], 'abnormal': [27], 'receptor': [29], '(AR)': [30], 'signaling': [31, 48, 57, 75, 153], 'persists': [32], 'and': [33, 80, 105, 140, 183, 221, 266, 295, 301, 320, 339], 'classic': [34], 'anti-androgens': [35, 308], 'such': [36], 'bicalutamide': [38, 253], 'are': [39], 'ineffective': [40], 'at': [41, 128, 154, 203], 'controlling': [42], 'tumor': [43, 264, 270], 'growth.': [44], 'The': [45], 'novel': [46], 'AR': [47, 56, 74, 115, 152, 317], 'inhibitor': [49], 'MDV3100': [50, 71, 91, 125, 145, 161, 195, 214, 241, 248, 262], 'has': [51], 'been': [52], 'demonstrated': [53], 'inhibit': [55, 316], 'in': [58, 76, 77, 81, 102, 113, 137, 141, 186, 190, 234, 254, 272, 291, 293, 296], 'preclinical': [59], 'models': [60, 79, 84, 298], 'CRPC.': [62, 86], 'Here,': [63], 'we': [64, 259], 'investigate': [65], 'further': [66], 'the': [67, 191, 227, 333], 'cellular': [68], 'effects': [69, 150], 'treatment': [72], 'on': [73, 151], 'vitro': [78, 294], 'vivo': [82, 297], 'xenograft': [83, 274], 'Our': [87], 'experiments': [88], 'reveal': [89], 'that': [90, 226, 261, 285, 302], '(>': [92, 162], '100': [93], 'nM)': [94], 'inhibits': [95], 'dihydrotestosterone': [96], '(DHT)': [97], 'induced': [98, 233, 267], 'AR-target': [99], 'gene': [100], 'expression': [101, 123], 'LNCaP': [103, 201], 'cells': [104, 202, 236], 'LNCaP/AR': [106, 220, 235, 280], 'cells,': [107], 'a': [108, 175, 273], 'CRPC': [109, 277, 300], 'cell': [110, 198, 217, 256, 322], 'culture': [111], 'model': [112, 275], 'which': [114], 'is': [116, 289], 'over-expressed.': [117], 'Inhibition': [118], 'Prostate-Specific': [120], 'Antigen': [121], 'mRNA': [122], 'by': [124, 312], 'was': [126, 232, 249], 'effective': [127, 290], 'concentrations': [129, 204], '10-fold': [130, 210], 'lower': [131, 211], 'than': [132, 212, 252], 'with': [133, 174, 238, 279], 'bicalutamide.': [134, 213], 'As': [135], 'evidenced': [136], 'other': [138, 307], 'studies': [139], 'contrast': [142, 158], 'bicalutamide,': [144, 160], 'did': [146], 'not': [147], 'display': [148], 'agonistic': [149], '10': [155], 'μM.': [156], '1': [163, 239], 'μM)': [164], 'inhibited': [165, 263], 'dependent': [167], 'nuclear': [168, 318], 'translocation': [169, 319], 'AR,': [171], 'measured': [173], 'quantitative': [176], 'optical': [177], 'based': [178], 'enzyme': [179], 'fragment': [180], 'complementation': [181], 'assay': [182], 'AR-YFP': [184], 'localization': [185], 'HEK-293': [187], 'cells.': [188, 223, 281], 'Furthermore,': [189], 'presence': [192], 'DHT,': [194], 'effectively': [196], 'reduced': [197], 'viability': [199, 218], '0.1': [208], 'μM,': [209], 'also': [215], 'decreased': [216], 'W741C-LNcaP': [222], 'We': [224], 'found': [225], 'apoptosis': [228], 'marker': [229], 'cleaved-caspase': [230], '3': [231], 'treated': [237], 'M': [240], 'for': [242], '48': [243], 'hours.': [244], 'Under': [245], 'these': [246], 'conditions,': [247], 'more': [250], 'potent': [251], 'decreasing': [255], 'viability.': [257], 'Finally,': [258], 'show': [260], 'growth': [265], 'regression': [268], 'volume': [271], 'generated': [278], 'These': [282], 'results': [283], 'demonstrate': [284], 'MDV3100,': [286], 'unlike': [287], 'anti-androgens,': [288], 'both': [292], 'its': [303, 313], 'mechanistic': [304], 'advantages': [305], 'over': [306], 'could': [309], 'be': [310], 'explained': [311], 'ability': [314], 'induce': [321], 'death.': [323], 'Citation': [324], 'Format:': [325], '{Authors}.': [326], '{Abstract': [327], 'title}': [328], '[abstract].': [329], 'In:': [330], 'Proceedings': [331], 'AACR-NCI-EORTC': [334], 'International': [335], 'Conference:': [336], 'Molecular': [337], 'Targets': [338], 'Cancer': [340, 352], 'Therapeutics;': [341], '2011': [342], 'Nov': [343], '12-16;': [344], 'San': [345], 'Francisco,': [346], 'CA.': [347], 'Philadelphia': [348], '(PA):': [349], 'AACR;': [350], 'Mol': [351], 'Ther': [353], '2011;10(11': [354], 'Suppl):Abstract': [355], 'nr': [356], 'A76.': [357]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2031154402', 'counts_by_year': [], 'updated_date': '2024-12-08T12:45:50.946333', 'created_date': '2016-06-24'}